Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy

Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy

Standard cancer chemotherapeutics often produce significant adverse effects and eventually lose their effectiveness due to the emergence of resistance mechanisms. As a result, patients with malignant tumors experience a poor quality of life and a short lifespan. Thus, combination medication regimens...

Full description

Bibliographic Details
Main Authors: Amir R. Afshari, Mehdi Sanati, Prashant Kesharwani, Amirhossein Sahebkar
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Functional Biomaterials
Subjects:
curcumin
cancer
combination therapy
drug delivery
drug resistance
Online Access:https://www.mdpi.com/2079-4983/14/8/408

Similar Items

Similar Items